Bradley Foster & Sargent Inc Clear Point Neuro, Inc. Transaction History
Bradley Foster & Sargent Inc
- $5.64 Billion
- Q1 2025
A detailed history of Bradley Foster & Sargent Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Bradley Foster & Sargent Inc holds 28,670 shares of CLPT stock, worth $317,950. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,670
Previous 56,663
49.4%
Holding current value
$317,950
Previous $871,000
60.96%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding CLPT
# of Institutions
105Shares Held
8.14MCall Options Held
243KPut Options Held
30.2K-
Vanguard Group Inc Valley Forge, PA1.28MShares$14.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny741KShares$8.22 Million0.01% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA482KShares$5.35 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$4.06 Million0.0% of portfolio
-
Brown Advisory Inc331KShares$3.67 Million0.01% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $272M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...